Effect of CRP and SAA Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections

NCT06568432 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19424

Last updated 2025-03-05

No results posted yet for this study

Summary

The study was a practical, cluster-randomized controlled trial to evaluate the impact of CRP and SAA point-of-care testing (CRP\&SAA POCT) on antibiotic prescribing in patients with acute respiratory-tract infections (ARI) at primary care facilities in rural China.

Conditions

  • Antibiotic Prescribing for Acute Respiratory-tract Infections

Interventions

DEVICE

CRP+SAA POCT

CRP+SAA POCT will be provided in 20 village clinics in the intervention group

Sponsors & Collaborators

  • University of Toronto

    collaborator OTHER
  • Huazhong University of Science and Technology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-15
Primary Completion
2025-08-15
Completion
2025-08-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06568432 on ClinicalTrials.gov